These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21516352)

  • 1. Oxidative stress in phenylketonuria: what is the evidence?
    Ribas GS; Sitta A; Wajner M; Vargas CR
    Cell Mol Neurobiol; 2011 Jul; 31(5):653-62. PubMed ID: 21516352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress in patients with phenylketonuria.
    Sirtori LR; Dutra-Filho CS; Fitarelli D; Sitta A; Haeser A; Barschak AG; Wajner M; Coelho DM; Llesuy S; Belló-Klein A; Giugliani R; Deon M; Vargas CR
    Biochim Biophys Acta; 2005 Apr; 1740(1):68-73. PubMed ID: 15878743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights from Animal Models on the Pathophysiology of Hyperphenylalaninemia: Role of Mitochondrial Dysfunction, Oxidative Stress and Inflammation.
    Wyse ATS; Dos Santos TM; Seminotti B; Leipnitz G
    Mol Neurobiol; 2021 Jun; 58(6):2897-2909. PubMed ID: 33550493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress in phenylketonuric patients.
    Vargas CR; Wajner M; Sitta A
    Mol Genet Metab; 2011; 104 Suppl():S97-9. PubMed ID: 21813309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Creatine plus pyruvate supplementation prevents oxidative stress and phosphotransfer network disturbances in the brain of rats subjected to chemically-induced phenylketonuria.
    Bortoluzzi VT; Brust L; Preissler T; de Franceschi ID; Wannmacher CMD
    Metab Brain Dis; 2019 Dec; 34(6):1649-1660. PubMed ID: 31352540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary biomarkers of oxidative stress and plasmatic inflammatory profile in phenylketonuric treated patients.
    Deon M; Sitta A; Faverzani JL; Guerreiro GB; Donida B; Marchetti DP; Mescka CP; Ribas GS; Coitinho AS; Wajner M; Vargas CR
    Int J Dev Neurosci; 2015 Dec; 47(Pt B):259-65. PubMed ID: 26456498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of oxidative stress parameters in treated phenylketonuric patients.
    Sitta A; Barschak AG; Deon M; Terroso T; Pires R; Giugliani R; Dutra-Filho CS; Wajner M; Vargas CR
    Metab Brain Dis; 2006 Dec; 21(4):287-96. PubMed ID: 17146735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that DNA damage is associated to phenylalanine blood levels in leukocytes from phenylketonuric patients.
    Sitta A; Manfredini V; Biasi L; Treméa R; Schwartz IV; Wajner M; Vargas CR
    Mutat Res; 2009; 679(1-2):13-6. PubMed ID: 19665577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of catalase and superoxide dismutase activities on oxidative stress in the brain of a phenylketonuria animal model and the effect of lipoic acid.
    Moraes TB; Jacques CE; Rosa AP; Dalazen GR; Terra M; Coelho JG; Dutra-Filho CS
    Cell Mol Neurobiol; 2013 Mar; 33(2):253-60. PubMed ID: 23232760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of short- and long-term exposition to high phenylalanine blood levels on oxidative damage in phenylketonuric patients.
    Sitta A; Barschak AG; Deon M; Barden AT; Biancini GB; Vargas PR; de Souza CF; Netto C; Wajner M; Vargas CR
    Int J Dev Neurosci; 2009 May; 27(3):243-7. PubMed ID: 19429389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental evidence that phenylalanine provokes oxidative stress in hippocampus and cerebral cortex of developing rats.
    Fernandes CG; Leipnitz G; Seminotti B; Amaral AU; Zanatta A; Vargas CR; Dutra Filho CS; Wajner M
    Cell Mol Neurobiol; 2010 Mar; 30(2):317-26. PubMed ID: 19774456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that L-carnitine and selenium supplementation reduces oxidative stress in phenylketonuric patients.
    Sitta A; Vanzin CS; Biancini GB; Manfredini V; de Oliveira AB; Wayhs CA; Ribas GO; Giugliani L; Schwartz IV; Bohrer D; Garcia SC; Wajner M; Vargas CR
    Cell Mol Neurobiol; 2011 Apr; 31(3):429-36. PubMed ID: 21191647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-carnitine protects DNA oxidative damage induced by phenylalanine and its keto acid derivatives in neural cells: a possible pathomechanism and adjuvant therapy for brain injury in phenylketonuria.
    Faverzani JL; Steinmetz A; Deon M; Marchetti DP; Guerreiro G; Sitta A; de Moura Coelho D; Lopes FF; Nascimento LVM; Steffens L; Henn JG; Ferro MB; Brito VB; Wajner M; Moura DJ; Vargas CR
    Metab Brain Dis; 2021 Oct; 36(7):1957-1968. PubMed ID: 34216350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathogenetic mechanisms in phenylketonuria: disorders affecting the metabolism of neurotransmitters and the antioxidant system].
    Ormazábal A; Artuch R; Vilaseca MA; García-Cazorla A; Campistol J
    Rev Neurol; 2004 Nov 16-30; 39(10):956-61. PubMed ID: 15573314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress in phenylketonuria: future directions.
    Rocha JC; Martins MJ
    J Inherit Metab Dis; 2012 May; 35(3):381-98. PubMed ID: 22116469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress in phenylketonuria-evidence from human studies and animal models, and possible implications for redox signaling.
    Bortoluzzi VT; Dutra Filho CS; Wannmacher CMD
    Metab Brain Dis; 2021 Apr; 36(4):523-543. PubMed ID: 33580861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenylketonuria oxidative stress and energy dysregulation: Emerging pathophysiological elements provide interventional opportunity.
    Dobrowolski SF; Phua YL; Vockley J; Goetzman E; Blair HC
    Mol Genet Metab; 2022 Jun; 136(2):111-117. PubMed ID: 35379539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-carnitine blood levels and oxidative stress in treated phenylketonuric patients.
    Sitta A; Barschak AG; Deon M; de Mari JF; Barden AT; Vanzin CS; Biancini GB; Schwartz IV; Wajner M; Vargas CR
    Cell Mol Neurobiol; 2009 Mar; 29(2):211-8. PubMed ID: 18814025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyruvate and creatine prevent oxidative stress and behavioral alterations caused by phenylalanine administration into hippocampus of rats.
    Berti SL; Nasi GM; Garcia C; Castro FL; Nunes ML; Rojas DB; Moraes TB; Dutra-Filho CS; Wannmacher CM
    Metab Brain Dis; 2012 Mar; 27(1):79-89. PubMed ID: 22101931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetrahydrobiopterin therapy vs phenylalanine-restricted diet: impact on growth in PKU.
    Aldámiz-Echevarría L; Bueno MA; Couce ML; Lage S; Dalmau J; Vitoria I; Andrade F; Llarena M; Blasco J; Alcalde C; Gil D; García MC; González-Lamuño D; Ruiz M; Ruiz MA; González D; Sánchez-Valverde F
    Mol Genet Metab; 2013 Aug; 109(4):331-8. PubMed ID: 23810227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.